June 9, 2023

Volume XIII, Number 160

Advertisement
Advertisement

June 08, 2023

Subscribe to Latest Legal News and Analysis

June 07, 2023

Subscribe to Latest Legal News and Analysis

June 06, 2023

Subscribe to Latest Legal News and Analysis
Advertisement

Climate Change Rules on the Horizon

The SEC has scheduled a meeting on March 21, 2022 at which it will, according to the posted agenda, “consider whether to propose amendments that would enhance and standardize registrants’ climate-related disclosures for investors.” SEC registrants and many practitioners have been anticipating a proposal regarding climate rules, particularly given the Commission’s recent statements concerning climate disclosure initiatives.

Copyright ©2023 Nelson Mullins Riley & Scarborough LLPNational Law Review, Volume XII, Number 73
Advertisement
Advertisement
Advertisement

About this Author

Erin Reeves McGinnis Securities Lawyer Nelson Mullins
Partner

Erin focuses her practice on securities transactions, including public and private offerings of securities, 1933 Act filings, 1934 Act reporting, corporate governance, SEC compliance, FINRA compliance, and general corporate matters, with a specific emphasis on real estate investment trusts (REITs). She also has significant experience with “Blue Sky” regulatory matters, as well as working with boards of directors and committees thereof, including agenda-setting. Additionally, she counsels clients seeking to create and raise capital through Qualified Opportunity Funds per the recently...

404-322-6208
Wes Scott Corporate Attorney Nelson Mullins Nashville Law Firm
Partner

Wes serves as primary outside counsel to public and private companies with respect to their securities offerings, SEC and FDIC reporting requirements, stock exchange listing compliance, M&A, and corporate governance and general corporate matters.  In particular, Wes focuses his practice on the financial institutions industry, including banks, bank holding companies, investment banks and other depositary institutions, the healthcare industry, including medical device, life sciences, clinical trial and healthcare IT companies, and the REIT industry, including public and private REITs,...

615-664-5304